News
-
-
PRESS RELEASE
Verisante Technology, Inc. Announces RTO Update:
SunRegen Healthcare AG closes $2.1 million private placement, advancing towards RTO with Verisante. SunRegen focuses on developing neurodegenerative drugs, starting with compound SBC003. Verisante to acquire 100% interest in SunRegen, aiming to qualify as Tier 2 Life Sciences Issuer -
-
-
-
-
-
PRESS RELEASE
Verisante Technology, Inc. Announces Exchange Acceptance of Shares for Debt Transaction
Verisante Technology, Inc. announces the approval of settlement shares for debt transaction by TSX-V Exchange and the board of directors. The Company to issue 5,600,000 Settlement Shares to officers in exchange for $56,000.00 of payables -
PRESS RELEASE
Verisante Technology, Inc. Announces 2023 AGM Results
-